CTI BioPharma Corp. Q1 Loss increases, but beats estimates

CTI BioPharma Corp. (CTIC) revealed Loss for its first quarter that increased from the same period last year but beat the Street estimates.

The company's earnings totaled -$37.18 million, or -$0.37 per share. This compares with -$17.27 million, or -$0.23 per share, in last year's first quarter.

Analysts on average had expected the company to earn -$0.41 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

CTI BioPharma Corp. earnings at a glance (GAAP) :

-Earnings (Q1): -$37.18 Mln. vs. -$17.27 Mln. last year.
-EPS (Q1): -$0.37 vs. -$0.23 last year.
-Analyst Estimate: -$0.41

For comments and feedback contact: editorial@rttnews.com

Follow RTT